Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket

Published 17/07/2023, 13:45
© Reuters. Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares surged 43.9% to $9.03 in pre-market trading after the company presented topline results from Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023.
  • PainReform Ltd. (NASDAQ: PRFX) shares gained 29.5% to $10.49 in pre-market trading. PainReform reported pricing of $1.5 million concurrent registered direct offering and private placement.
  • Nova LifeStyle, Inc. (NASDAQ: NVFY) rose 27.7% to $2.81 in pre-market trading after declining over 6% on Friday.
  • argenx SE (NASDAQ: ARGX) shares rose 24.3% to $471.47 in pre-market trading after reporting topline data from ADHERE study of VYVGART hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.
  • AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 23.3% to $0.6801 in pre-market trading.
  • BridgeBio Pharma, Inc. (NASDAQ: BBIO) gained 20.5% to $21.98 in pre-market trading after the company's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy met its primary endpoint.
  • Nuvve Holding Corp. (NASDAQ: NVVE) rose 13.3% to $0.68 in pre-market trading after declining around 6% on Friday.
  • Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares gained 13.2% to $1.46 in pre-market trading. Cadrenal Therapeutics reported closing of $7.5 million private placement priced at-the-market under Nasdaq rules.
  • Edgio, Inc. (NASDAQ: EGIO) shares climbed 12.8% to $0.91 in pre-market trading.
  • Genprex, Inc. (NASDAQ: GNPX) gained 10.3% to $0.9090 in pre-market trading. Genprex recently reported positive results from Phase 1 Acclaim-1 clinical trial.
Losers
  • BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) fell 39.8% to $1.80 in pre-market trading after the company reported a proposed underwritten public offering.
  • ViewRay, Inc. (NASDAQ: VRAY) fell 24.7% to $0.2739 in pre-market trading after the company filed voluntary Chapter 11 petitions.
  • Ebix, Inc. (NASDAQ: EBIX) fell 21.6% to $19.40 in pre-market trading. Ebix, issued an informational release with a few clarifications and updates to the previously issued strategic update release on July 14, 2023.
  • Frequency Therapeutics, Inc. (NASDAQ: FREQ) fell 16.5% to $0.5925 in pre-market trading. Frequency Therapeutics shares jumped 77% on Friday after the company agreed to merge with Korro Bio in an all- stock transaction.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares dropped 14.8% to $72.00 in pre-market trading.
  • Minerva Surgical, Inc. (NASDAQ: UTRS) fell 14.3% to $0.26 in pre-market after jumping 23% on Friday. Minerva Surgical received a notice of allowance for its US patent application 17/569,850 titled "Tissue Extraction Devices And Methods."
  • Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares fell 12.7% to $8.99 in pre-market trading after gaining more than 28% on Friday.
  • Western Acquisition Ventures Corp. (NASDAQ: WAVS) shares fell 8.8% to $11.25 in pre-market trading after climbing over 18% on Friday.
  • Monopar Therapeutics Inc. (NASDAQ: MNPR) fell 9.7% to $0.9034 in pre-market trading after jumping 17% on Friday.
  • 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) fell 7.8% to $3.52 in pre-market trading after declining over 15% on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Market Volatility Declines; S&P 500 Settles Lower But Posts Weekly Gain

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.